Cargando…

Molecular profiling of childhood cancer: Biomarkers and novel therapies

BACKGROUND: Technological advances including high-throughput sequencing have identified numerous tumor-specific genetic changes in pediatric and adolescent cancers that can be exploited as targets for novel therapies. SCOPE OF REVIEW: This review provides a detailed overview of recent advances in th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Saletta, Federica, Wadham, Carol, Ziegler, David S., Marshall, Glenn M., Haber, Michelle, McCowage, Geoffrey, Norris, Murray D., Byrne, Jennifer A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2014
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4633945/ https://www.ncbi.nlm.nih.gov/pubmed/26675306 http://dx.doi.org/10.1016/j.bbacli.2014.06.003

Ejemplares similares

Neuroblastoma Molecular Risk-Stratification of DNA Copy Number and ALK Genotyping via Cell-Free Circulating Tumor DNA Profiling
por: Kahana-Edwin, Smadar, et al.
Publicado: (2021)

NFB-18. IMMUNE FUNCTION IN CHILDREN TREATED WITH TRAMETINIB
por: Moukhaiber, Perla, et al.
Publicado: (2020)

Polyamine pathway inhibition as a novel therapeutic approach to treating neuroblastoma
por: Gamble, Laura D., et al.
Publicado: (2012)

Psychosocial Assessment Using Telehealth in Adolescents and Young Adults With Cancer: A Partially Randomized Patient Preference Pilot Study
por: Chalmers, John Alexander, et al.
Publicado: (2018)

Ub-ISAP: a streamlined UNIX pipeline for mining unique viral vector integration sites from next generation sequencing data
por: Kamboj, Atul, et al.
Publicado: (2017)

Integration of genomics, high throughput drug screening, and personalized xenograft models as a novel precision medicine paradigm for high risk pediatric cancer
por: Tsoli, Maria, et al.
Publicado: (2018)

In vitro and in vivo drug screens of tumor cells identify novel therapies for high‐risk child cancer
por: Lau, Loretta M S, et al.
Publicado: (2021)

Accelerating development of high-risk neuroblastoma patient-derived xenograft models for preclinical testing and personalised therapy
por: Kamili, Alvin, et al.
Publicado: (2020)

Diffuse leptomeningeal glioneuronal tumour (DLGNT) in children: the emerging role of genomic analysis
por: Manoharan, Neevika, et al.
Publicado: (2021)

DIPG-83. USING COPPER CHELATING AGENTS TO TARGET RECEPTOR TYROSINE KINASE SIGNALLING IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Michniewicz, Filip, et al.
Publicado: (2020)

Enhancing the anti-angiogenic action of histone deacetylase inhibitors
por: Kuljaca, Selena, et al.
Publicado: (2007)

DIPG-32. AKT SIGNALING DRIVES RESISTANCE TO ONC201 IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Jackson, Evangeline R, et al.
Publicado: (2020)

A novel transcriptional signature identifies T-cell infiltration in high-risk paediatric cancer
por: Mayoh, Chelsea, et al.
Publicado: (2023)

TRIM16 overexpression induces apoptosis through activation of caspase-2 in cancer cells
por: Kim, Patrick Y., et al.
Publicado: (2013)

MBCL-26. FACTORS ASSOCIATED WITH LONGER SURVIVAL AFTER FIRST RECURRENCE IN MEDULLOBLASTOMA BY MOLECULAR SUBGROUP AFTER RISK-BASED INITIAL THERAPY
por: Chintagumpala, Murali, et al.
Publicado: (2020)

ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux
por: Henderson, Michelle J., et al.
Publicado: (2011)

PD‐1 blockade using pembrolizumab in adolescent and young adult patients with advanced bone and soft tissue sarcoma
por: Scheinberg, Tahlia, et al.
Publicado: (2020)

ABCC4/MRP4: a MYCN-regulated transporter and potential therapeutic target in neuroblastoma
por: Huynh, Tony, et al.
Publicado: (2012)

DIPG-16. COMBINATION OF ARGININE DEPLETION AND POLYAMINE INHIBITION AS AN ANTICANCER STRATEGY FOR DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Khan, Aaminah, et al.
Publicado: (2020)

DIPG-15. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
por: Khan, Aaminah, et al.
Publicado: (2020)

RARE-02. POLYAMINE PATHWAY INHIBITION IS A POTENT NOVEL THERAPEUTIC STRATEGY AGAINST DIFFUSE INTRINSIC PONTINE GLIOMA
por: Khan, Aaminah, et al.
Publicado: (2021)

Malignant Melanoma in Children and Adolescents Treated in Pediatric Oncology Centers: An Australian and New Zealand Children’s Oncology Group (ANZCHOG) Study
por: Ryan, Anne L., et al.
Publicado: (2021)

Literacy transforms speech production
por: Saletta, Meredith
Publicado: (2015)

LGG-09. CLINICAL ACTIVITY OF PAN-RAF INHIBITOR TOVORAFENIB IN THE REGISTRATIONAL PEDIATRIC LOW-GRADE GLIOMA ARM OF THE PHASE 2 FIREFLY-1 (PNOC026) STUDY
por: Kilburn, Lindsay, et al.
Publicado: (2023)

Defining Higher-Risk Chronic Myeloid Leukemia: Risk Scores, Genomic Landscape, and Prognostication
por: Shahrin, Nur Hezrin, et al.
Publicado: (2022)

The Interface Between Reading and Handwriting
por: Saletta Fitzgibbons, Meredith
Publicado: (2022)

Transcriptome profiling of caspase-2 deficient EμMyc and Th-MYCN mouse tumors identifies distinct putative roles for caspase-2 in neuronal differentiation and immune signaling
por: Dorstyn, Loretta, et al.
Publicado: (2019)

DIPG-75. PRECISION MEDICINE FOR PAEDIATRIC HIGH-GRADE DIFFUSE MIDLINE GLIOMAS - RESULTS FROM THE ZERO CHILDHOOD CANCER COMPREHENSIVE PRECISION MEDICINE PROGRAM
por: Khuong-Quang, Dong-Anh, et al.
Publicado: (2020)

The role of sphingolipid signalling in diabetes-associated pathologies (Review)
por: Ng, Mei Li, et al.
Publicado: (2017)

A G316A Polymorphism in the Ornithine Decarboxylase Gene Promoter Modulates MYCN-Driven Childhood Neuroblastoma
por: Gamble, Laura D., et al.
Publicado: (2021)

Molecular Profiling of Hard-to-Treat Childhood and Adolescent Cancers
por: Khater, Fida, et al.
Publicado: (2019)

Novel biomarkers of childhood and adolescent obesity
por: Yanes Cardozo, Licy L., et al.
Publicado: (2021)

Hopes, concerns, satisfaction and regret in a precision medicine trial for childhood cancer: a mixed-methods study of parent and patient perspectives
por: Wakefield, Claire E., et al.
Publicado: (2023)

A biomarker discovery framework for childhood anxiety
por: Bosl, William J., et al.
Publicado: (2023)

Dextran-Curcumin Nanosystems Inhibit Cell Growth and Migration Regulating the Epithelial to Mesenchymal Transition in Prostate Cancer Cells
por: Bevacqua, Emilia, et al.
Publicado: (2021)

In-Field Implementation of a Recombinant Factor C Assay for the Detection of Lipopolysaccharide as a Biomarker of Extant Life within Glacial Environments
por: Barnett, Megan J., et al.
Publicado: (2012)

DIPG-20. Copper chelation therapy targets S-adenosylmethionine (SAM) metabolism and epigenetic regulators in diffuse intrinsic pontine glioma (DIPG)
por: Michniewicz, Filip, et al.
Publicado: (2022)

Histone deacetylase 2 and N-Myc reduce p53 protein phosphorylation at serine 46 by repressing gene transcription of tumor protein 53-induced nuclear protein 1
por: Shahbazi, Jeyran, et al.
Publicado: (2014)

Improving the Identification of High Risk Precursor B Acute Lymphoblastic Leukemia Patients with Earlier Quantification of Minimal Residual Disease
por: Karsa, Mawar, et al.
Publicado: (2013)

The long noncoding RNA MALAT1 promotes tumor-driven angiogenesis by up-regulating pro-angiogenic gene expression
por: Tee, Andrew E., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_pa2b1an65ss6cfn8loepbu3shu